# OnCo record nct06157827 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06157827/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06157827", "NCT06157827" ;
  schema:name "A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma"@en ;
  schema:description "A phase 1/2 trial of Opamtistomig run by Nanjing Leads Biolabs Co.,Ltd, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06157827/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06157827> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> ;
  onco:drugs <https://onco.cc/drugs/opamtistomig/> ;
  onco:companies <https://onco.cc/companies/nanjing-leads-biolabs/> .